Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells
We explored the effect of transforming growth factor β (TGF-β), a cytokine that appears to play a central role in inflammatory events, on albumin expression by normal adult human hepatocytes and hepatoma cells. Addition of TGF-β to primary human hepatocyte cultures resulted in a dramatic decrease in...
Gespeichert in:
Veröffentlicht in: | Biochemical and biophysical research communications 1990-09, Vol.171 (2), p.647-654 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 654 |
---|---|
container_issue | 2 |
container_start_page | 647 |
container_title | Biochemical and biophysical research communications |
container_volume | 171 |
creator | Busso, Nathalie Chesne, Christophe Delers, François Morel, Fabrice Guillouzo, André |
description | We explored the effect of transforming growth factor β (TGF-β), a cytokine that appears to play a central role in inflammatory events, on albumin expression by normal adult human hepatocytes and hepatoma cells. Addition of TGF-β to primary human hepatocyte cultures resulted in a dramatic decrease in albumin accumulation and synthesis. This effect was dose-dependent, took place after a 48h incubation period and was maintained over 96h. TGF-β-decreased albumin protein levels were associated with reduced albumin mRNA content. Actin mRNA levels were concomittantly increased. Comparable qualitative effects of TGF-β were observed on human hepatoma HepG2 cells. |
doi_str_mv | 10.1016/0006-291X(90)91195-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80014814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006291X9091195X</els_id><sourcerecordid>80014814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-5b2c4099794c4478dbfc8fc1730597715c87f2c5ac84936664ed73a5dca64f603</originalsourceid><addsrcrecordid>eNqFkdFKwzAYhYMoOqdvoJArmRfVpE3T5kaQ4aYw8GbC7kKapjbSpjNJlb2WD-IzmbqxS736Iec7f37OAeACoxuMML1FCNEoZng1YeiaYczSaHUARhgxFMUYkUMw2iMn4NS5N4QwJpQdg-MYU5YlaAQ2SyuMqzrbavMKX2336euoEtJ3Nvr-gpPlfBbmNdSm1oX2Doqm6AML3cb4WjntggRN8IsG1n0rDKzVWvhObrwKtCkHffvUCvio1vMYStU07gwcVaJx6nw3x-Bl9rCcPkaL5_nT9H4RSZIwH6VFLAliLGNEEpLlZVHJvJI4XJ-yLMOpzLMqlqmQOWEJpZSoMktEWkpBSUVRMgZX271r2733ynneajdcIIzqesfzkArJMfkXxCmLaRoPINmC0nbOWVXxtdWtsBuOER-q4UPufMidM8R_q-GrYLvc7e-LVpV7066LoN9tdRXS-NDKcie1MlKV2irpednpvz_4AeTGn88</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15926524</pqid></control><display><type>article</type><title>Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Busso, Nathalie ; Chesne, Christophe ; Delers, François ; Morel, Fabrice ; Guillouzo, André</creator><creatorcontrib>Busso, Nathalie ; Chesne, Christophe ; Delers, François ; Morel, Fabrice ; Guillouzo, André</creatorcontrib><description>We explored the effect of transforming growth factor β (TGF-β), a cytokine that appears to play a central role in inflammatory events, on albumin expression by normal adult human hepatocytes and hepatoma cells. Addition of TGF-β to primary human hepatocyte cultures resulted in a dramatic decrease in albumin accumulation and synthesis. This effect was dose-dependent, took place after a 48h incubation period and was maintained over 96h. TGF-β-decreased albumin protein levels were associated with reduced albumin mRNA content. Actin mRNA levels were concomittantly increased. Comparable qualitative effects of TGF-β were observed on human hepatoma HepG2 cells.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/0006-291X(90)91195-X</identifier><identifier>PMID: 2169730</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Carcinoma, Hepatocellular ; Cell Line ; Cells, Cultured ; DNA Probes ; Humans ; Liver - drug effects ; Liver - metabolism ; Liver Neoplasms ; Male ; Molecular Weight ; Recombinant Proteins - pharmacology ; RNA, Messenger - drug effects ; RNA, Messenger - genetics ; Serum Albumin - biosynthesis ; Serum Albumin - genetics ; Serum Albumin - isolation & purification ; Transcription, Genetic ; Transforming Growth Factors - pharmacology</subject><ispartof>Biochemical and biophysical research communications, 1990-09, Vol.171 (2), p.647-654</ispartof><rights>1990</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-5b2c4099794c4478dbfc8fc1730597715c87f2c5ac84936664ed73a5dca64f603</citedby><cites>FETCH-LOGICAL-c439t-5b2c4099794c4478dbfc8fc1730597715c87f2c5ac84936664ed73a5dca64f603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0006291X9091195X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2169730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busso, Nathalie</creatorcontrib><creatorcontrib>Chesne, Christophe</creatorcontrib><creatorcontrib>Delers, François</creatorcontrib><creatorcontrib>Morel, Fabrice</creatorcontrib><creatorcontrib>Guillouzo, André</creatorcontrib><title>Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>We explored the effect of transforming growth factor β (TGF-β), a cytokine that appears to play a central role in inflammatory events, on albumin expression by normal adult human hepatocytes and hepatoma cells. Addition of TGF-β to primary human hepatocyte cultures resulted in a dramatic decrease in albumin accumulation and synthesis. This effect was dose-dependent, took place after a 48h incubation period and was maintained over 96h. TGF-β-decreased albumin protein levels were associated with reduced albumin mRNA content. Actin mRNA levels were concomittantly increased. Comparable qualitative effects of TGF-β were observed on human hepatoma HepG2 cells.</description><subject>Adult</subject><subject>Carcinoma, Hepatocellular</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>DNA Probes</subject><subject>Humans</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver Neoplasms</subject><subject>Male</subject><subject>Molecular Weight</subject><subject>Recombinant Proteins - pharmacology</subject><subject>RNA, Messenger - drug effects</subject><subject>RNA, Messenger - genetics</subject><subject>Serum Albumin - biosynthesis</subject><subject>Serum Albumin - genetics</subject><subject>Serum Albumin - isolation & purification</subject><subject>Transcription, Genetic</subject><subject>Transforming Growth Factors - pharmacology</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdFKwzAYhYMoOqdvoJArmRfVpE3T5kaQ4aYw8GbC7kKapjbSpjNJlb2WD-IzmbqxS736Iec7f37OAeACoxuMML1FCNEoZng1YeiaYczSaHUARhgxFMUYkUMw2iMn4NS5N4QwJpQdg-MYU5YlaAQ2SyuMqzrbavMKX2336euoEtJ3Nvr-gpPlfBbmNdSm1oX2Doqm6AML3cb4WjntggRN8IsG1n0rDKzVWvhObrwKtCkHffvUCvio1vMYStU07gwcVaJx6nw3x-Bl9rCcPkaL5_nT9H4RSZIwH6VFLAliLGNEEpLlZVHJvJI4XJ-yLMOpzLMqlqmQOWEJpZSoMktEWkpBSUVRMgZX271r2733ynneajdcIIzqesfzkArJMfkXxCmLaRoPINmC0nbOWVXxtdWtsBuOER-q4UPufMidM8R_q-GrYLvc7e-LVpV7066LoN9tdRXS-NDKcie1MlKV2irpednpvz_4AeTGn88</recordid><startdate>19900914</startdate><enddate>19900914</enddate><creator>Busso, Nathalie</creator><creator>Chesne, Christophe</creator><creator>Delers, François</creator><creator>Morel, Fabrice</creator><creator>Guillouzo, André</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>19900914</creationdate><title>Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells</title><author>Busso, Nathalie ; Chesne, Christophe ; Delers, François ; Morel, Fabrice ; Guillouzo, André</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-5b2c4099794c4478dbfc8fc1730597715c87f2c5ac84936664ed73a5dca64f603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Carcinoma, Hepatocellular</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>DNA Probes</topic><topic>Humans</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver Neoplasms</topic><topic>Male</topic><topic>Molecular Weight</topic><topic>Recombinant Proteins - pharmacology</topic><topic>RNA, Messenger - drug effects</topic><topic>RNA, Messenger - genetics</topic><topic>Serum Albumin - biosynthesis</topic><topic>Serum Albumin - genetics</topic><topic>Serum Albumin - isolation & purification</topic><topic>Transcription, Genetic</topic><topic>Transforming Growth Factors - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busso, Nathalie</creatorcontrib><creatorcontrib>Chesne, Christophe</creatorcontrib><creatorcontrib>Delers, François</creatorcontrib><creatorcontrib>Morel, Fabrice</creatorcontrib><creatorcontrib>Guillouzo, André</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busso, Nathalie</au><au>Chesne, Christophe</au><au>Delers, François</au><au>Morel, Fabrice</au><au>Guillouzo, André</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>1990-09-14</date><risdate>1990</risdate><volume>171</volume><issue>2</issue><spage>647</spage><epage>654</epage><pages>647-654</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>We explored the effect of transforming growth factor β (TGF-β), a cytokine that appears to play a central role in inflammatory events, on albumin expression by normal adult human hepatocytes and hepatoma cells. Addition of TGF-β to primary human hepatocyte cultures resulted in a dramatic decrease in albumin accumulation and synthesis. This effect was dose-dependent, took place after a 48h incubation period and was maintained over 96h. TGF-β-decreased albumin protein levels were associated with reduced albumin mRNA content. Actin mRNA levels were concomittantly increased. Comparable qualitative effects of TGF-β were observed on human hepatoma HepG2 cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>2169730</pmid><doi>10.1016/0006-291X(90)91195-X</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 1990-09, Vol.171 (2), p.647-654 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_80014814 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Carcinoma, Hepatocellular Cell Line Cells, Cultured DNA Probes Humans Liver - drug effects Liver - metabolism Liver Neoplasms Male Molecular Weight Recombinant Proteins - pharmacology RNA, Messenger - drug effects RNA, Messenger - genetics Serum Albumin - biosynthesis Serum Albumin - genetics Serum Albumin - isolation & purification Transcription, Genetic Transforming Growth Factors - pharmacology |
title | Transforming growth-factor-β (TGF-β) inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A05%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transforming%20growth-factor-%CE%B2%20(TGF-%CE%B2)%20inhibits%20albumin%20synthesis%20in%20normal%20human%20hepatocytes%20and%20in%20hepatoma%20HepG2%20cells&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Busso,%20Nathalie&rft.date=1990-09-14&rft.volume=171&rft.issue=2&rft.spage=647&rft.epage=654&rft.pages=647-654&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/0006-291X(90)91195-X&rft_dat=%3Cproquest_cross%3E80014814%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15926524&rft_id=info:pmid/2169730&rft_els_id=0006291X9091195X&rfr_iscdi=true |